Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inflammatory skin disease formula (ISDF) is an empirical Chinese medicine formula developed by Professor Zhi-Xiu Lin at the School of Chinese Medicine, The Chinese University of Hong Kong. It has been prescribed for many years and observed to be effective in relieving clinical manifestations of atopic dermatitis and psoriasis. The formula contains nine Chinese herbal medicines, including Rehmanniae Radix, Paeoniae Radix Rubra, Scutellariae Radix, Phellodendri Cortex, Forsythiae Fructus, Plantaginis Semen, Vignae Semen, Dictamni Cortex, and Kochiae Fructus. Preclinical studies suggest ISDF inhibits inflammation through the inactivation of the NF-κB p65 pathway, leading to decreased epidermal thickening and mast cell infiltration. Key active components like baicalin, berberine, and paeoniflorin contribute to its anti-inflammatory and anti-psoriatic effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Inflammatory skin disease formula.